Mitsubishi UFJ Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-27,100
Closed -$938K 841
2014
Q4
$938K Buy
27,100
+9,400
+53% +$334K 0.03% 560
2014
Q3
$683K Buy
17,700
+7,100
+67% +$265K 0.02% 613
2014
Q2
$413K Sell
10,600
-4,400
-29% -$164K 0.01% 660
2014
Q1
$513K Buy
+15,000
New +$465K 0.01% 627

Other funds holding MYGN

Mitsubishi UFJ Asset Management's MYGN Position: Q1 2015 in Review

Mitsubishi UFJ Asset Management sold out of Myriad Genetics (MYGN) in Q1 2015, closing a stake of 27,100 shares — an estimated $938K sold.

Mitsubishi UFJ Asset Management first reported a position in MYGN in Q1 2014 and held it in 4 quarters. The position peaked at $938K in Q4 2014. 251 funds tracked by Wall St. Rank hold MYGN as of Q1 2015.

  • Mitsubishi UFJ Asset Management reported no remaining Myriad Genetics position as of Q1 2015 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 27,100 Myriad Genetics shares in Q1 2015, an estimated $938K.
  • Mitsubishi UFJ Asset Management first reported a position in Myriad Genetics in Q1 2014 and held it in 4 quarters.
  • Mitsubishi UFJ Asset Management's Myriad Genetics position peaked at $938K in Q4 2014.
  • 251 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2015.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2015, filed 30 Apr 2015.